C8R.SI stock trades at S$0.022 intraday after Jiutian Chemical Group Limited reported earnings on 04 Mar 2026. The share is down -4.35% from yesterday on volume of 1,930,100 as markets weigh a small loss per share (EPS -0.01) and weak margins. Investors should view today’s move in the context of trailing metrics: year high S$0.032, year low S$0.021, and average 50-day price near S$0.024 on the SES in Singapore. This article breaks down the earnings detail, financial ratios, technicals, and Meyka AI’s forecast for traders watching C8R.SI stock intraday

Earnings snapshot and market reaction for C8R.SI stock

Jiutian Chemical (C8R.SI) reported results tied to the earnings announcement dated 04 Mar 2026. The company shows EPS of -0.01 and a negative PE of -2.30, which underpins today’s intraday weakness. Volume of 1,930,100 shares traded, near the stock’s average volume of 1,916,508, suggesting genuine selling rather than an outlier spike.

Market reaction is linked to margin pressure and revenue contraction in FY2025, where revenue fell about 56.43% year-on-year. Traders should treat today’s move as earnings-driven repricing rather than a macro-driven liquidity event

C8R.SI stock financials and valuation metrics

Key balance-sheet and valuation data point to mixed fundamentals. Book value per share is S$0.227 while cash per share is S$0.100, giving liquidation comfort versus the current price of S$0.022. Price-to-book sits at 0.55, indicating the market values the company below its book equity.

Profitability is weak: return on equity is -30.86% and operating cash flow per share is -0.07. Days sales outstanding is long at 393.45 days, exposing receivables collection risk and working capital strain.

Meyka AI grades and C8R.SI stock forecast

“Meyka AI rates C8R.SI with a score out of 100”. Meyka AI rates C8R.SI with a score of 58.79 out of 100 — Grade C+, Suggestion: HOLD. This grade factors S&P 500 and sector comparisons, financial growth, key metrics, forecasts, and analyst consensus. These grades are not guaranteed and we are not financial advisors.

Meyka AI’s forecast model projects S$0.027 by year-end, versus the current S$0.022, implying an upside of +22.73%. Forecasts are model-based projections and not guarantees.

Technicals and trading signals for C8R.SI stock

Intraday technicals show a neutral to slightly bearish tone. RSI is 43.09 and the CCI flags oversold conditions at -122.36, suggesting short-term weakness but possible near-term relief rallies. The 50-day average near S$0.024 and 200-day average near S$0.026 are resistance levels to watch.

Volume matched the average, so moves are price-driven. Traders should watch support at the year low S$0.021 and resistance in the S$0.024–0.026 band for short-term entries or exits.

Risks, catalysts and sector context for C8R.SI stock

Key risks include continued negative margins, slow receivables collection, and demand volatility in chemical feedstocks. Debt metrics are moderate with debt-to-equity near 0.28, but interest coverage is negative which raises financing risk if cash flows do not improve.

Catalysts that could re-rate the stock: improved working capital management, recovery in specialty chemical prices, or clearer guidance from management on isotope and R&D commercialization. Compare peers using market tools to judge relative recovery potential Investing comparison 1 and Investing comparison 2.

Price targets and practical intraday strategy for C8R.SI stock

Analyst-style price targets for trading frames: conservative target S$0.027 (Meyka AI yearly forecast), base target S$0.030, and optimistic recovery S$0.040 if margins and receivables improve. A stop-loss near S$0.020 protects capital on downside volatility.

Intraday traders should use tight risk controls. Consider scaling in under S$0.022 with size limits and using the S$0.024–0.026 area as the first profit-taking band. For longer-term investors, monitor quarterly cash flows and management updates on isotope sales and R&D commercialisation

Final Thoughts

C8R.SI stock sits at S$0.022 intraday after the 04 Mar 2026 earnings release, reflecting weak EPS and margin pressure. The company shows asset coverage with book value S$0.227 per share and cash S$0.100 per share, but profitability and receivables remain key concerns. Meyka AI’s model projects S$0.027 by year-end, implying +22.73% upside versus current price; this projection is model-based and not guaranteed. Our takeaway: the stock is a risky hold for longer-term investors seeking a turnaround, and an active short-term trade for disciplined intraday traders. Use support at S$0.021 and resistance near S$0.024–0.026, and watch management commentary and cash flow improvements before adding size. Meyka AI is the AI-powered market analysis platform used to generate grade and forecast signals

FAQs

Disclaimer:

Stock markets involve risks. This content is for informational purposes only. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.